| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1.7 | 0.1 | 0.0 |
| Total income | 1.7 | 0.1 | 0.0 |
| Profit before exceptional items & tax | -0.0 | -5.3 | -0.0 |
| Profit before tax | -0.0 | -5.3 | -0.0 |
| Net profit | -0.0 | -5.3 | -0.0 |
| Operating margin | 0.0% | n/m | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, BSE: 519353. Figures extracted from the filing.
Bansisons Tea Industries Ltd: key numbers
- Share price
- ₹8.71
- Market cap
- ₹5.51 Cr
- Revenue (annual)
- ₹0.10 Cr
- Net profit (annual)
- ₹-5.37 Cr
- P/E (TTM)
- -1.0×Sector 28.6×
- Promoter holding
- 23.15%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bansisons Tea Industries Ltd
All →Novyra Pharmachem Other Announcement
Novyra Pharmachem intimated BSE of a change in its official email ID under Reg 30. The update is purely administrative with no business or financial impact.
Bansisons Tea Industries Other Announcement
The company has officially changed its name from Bansisons Tea Industries Limited to Novyra Pharmachem Limited. This change reflects the company's expansion into the pharmaceutical sector.
Bansisons Tea Industries Board Meeting Date
Novyra Pharmachem Limited has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Bansisons Tea Industries Other Announcement
Novyra Pharmachem Limited has updated its official website address. The change is being intimated to the exchange for record-keeping purposes.
Bansisons Tea Industries Other Announcement
Bansisons Tea Industries Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Bansisons Tea Industries Annual General Meeting
Novyra Pharmachem Limited held its 39th AGM on June 25, 2026 via video conference. The meeting adopted audited accounts, re-appointed a director and approved a capital reduction scheme.